Tumour-derived interleukin 1a increases soluble ICAM-1 release by endothelial cells
Author Information
Author(s): E Fonsatti, M Altomonte, S Coral, I Cattarossi, MR Nicotra, A Gasparollo, PG Natali, M Maio
Primary Institution: Istituto Nazionale di Ricovero e Cura a Carattere Scientifico-Centro di Riferimento Oncologico, Avano, Italy
Hypothesis
Does tumour-derived interleukin 1a (IL-1a) up-regulate the release of soluble intercellular adhesion molecule-1 (sICAM-1) by endothelial cells?
Conclusion
Tumour-derived IL-1a significantly increases the release of sICAM-1 by human umbilical vein endothelial cells.
Supporting Evidence
- IL-1a was detectable in conditioned media from HT-1080 and 5637 cells.
- Endothelial cells showed increased sICAM-1 release when cultured with conditioned media from neoplastic cells.
- The addition of anti-IL-1a neutralizing antibodies completely abolished the up-regulation of sICAM-1.
Takeaway
When cancer cells release a substance called IL-1a, it makes blood vessel cells release more of a molecule called sICAM-1, which helps cancer cells avoid being attacked by the immune system.
Methodology
The study used conditioned media from seven neoplastic cell lines to assess the effect of IL-1a on sICAM-1 release by human umbilical vein endothelial cells (HUVECs).
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website